Increasing imipenem resistance and dissemination of the ISAba1-associated blaOXA-23 gene among Acinetobacter baumannii isolates in an intensive care unit
The antibiotic susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii complex strains recovered from the intensive care unit (ICU) of West China Hospital, Sichuan, PR China, from 2006 to 2009 was investigated. The identification of A. baumannii and analysis of carbapenemase-encoding genes and their relationship with ISAba1 were performed by PCR. Furthermore, a DiversiLab repetitive extragenic palindromic sequence-based PCR (rep-PCR) microbial typing system and a multilocus sequence typing (MLST) scheme were applied to assess the genetic relationship of the isolates. The results showed that the antibiotic susceptibility of the A. calcoaceticus–A. baumannii complex isolates changed and imipenem resistance increased rapidly between 2006 and 2009. The blaOXA-51-like and ISAba1-associated blaOXA-23 genes were prevalent in the imipenem-resistant A. baumannii isolates. However, the blaOXA-58-like gene was found in only one isolate and no metallo-β-lactamase genes were detected. The representative multidrug-resistant A. baumannii isolates were identified as one cluster by rep-PCR fingerprinting and belonged to the clonal complex 92 (CC92) according to MLST. These findings indicate a situation of increasing resistance and wide distribution of class D β-lactamase genes, especially the acquired ISAba1-associated blaOXA-23 gene, in A. baumannii isolates in the ICU of West China Hospital, probably caused by expansion of the CC92 clone.
BartualS. G.,
SeifertH.,
HipplerC.,
LuzonM. A.,
WisplinghoffH.,
Rodriguez-ValeraF.2005; Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii
. J Clin Microbiol 43:4382–4390[CrossRef]
CorvecS.,
PoirelL.,
NaasT.,
DrugeonH.,
NordmannP.2007; Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene bla OXA-23 in Acinetobacter baumannii
. Antimicrob Agents Chemother 51:1530–1533[CrossRef]
DonnarummaF.,
SergiS.,
IndoratoC.,
MastromeiG.,
MonnanniR.,
NicolettiP.,
PecileP.,
CecconiD.,
ManninoR.other authors2010; Molecular characterization of Acinetobacter isolates collected in intensive care units of six hospitals in Florence, Italy, during a 3-year surveillance program: a population structure analysis. J Clin Microbiol 48:1297–1304[CrossRef]
FalagasM. E.,
KarageorgopoulosD. E.2008; Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis 46:1121–1122 author reply 1122 [CrossRef]
FeilE. J.,
LiB. C.,
AanensenD. M.,
HanageW. P.,
SprattB. G.2004; eburst: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol 186:1518–1530[CrossRef]
FontanaC.,
FavaroM.,
MinelliS.,
BossaM. C.,
TestoreG. P.,
LeonardisF.,
NatoliS.,
FavalliC.2008; Acinetobacter baumannii in intensive care unit: a novel system to study clonal relationship among the isolates. BMC Infect Dis 8:79[CrossRef]
HanbergerH.,
Garcia-RodriguezJ. A.,
GobernadoM.,
GoossensH.,
NilssonL. E.,
StruelensM. J.1999; Antibiotic susceptibility among aerobic Gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. JAMA 281:67–71[CrossRef]
KohlenbergA.,
BrummerS.,
HigginsP. G.,
SohrD.,
PieningB. C.,
de GrahlC.,
HalleE.,
RudenH.,
SeifertH.2009; Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre. J Med Microbiol 58:1499–1507[CrossRef]
LepapeA.,
MonnetD. L.2009; Experience of European intensive care physicians with infections due to antibiotic-resistant bacteria, 2009. Euro Surveill 14:pii 19391
MugnierP. D.,
PoirelL.,
NordmannP.2009; Functional analysis of insertion sequence IS Aba1 , responsible for genomic plasticity of Acinetobacter baumannii
. J Bacteriol 191:2414–2418[CrossRef]
MugnierP. D.,
PoirelL.,
NaasT.,
NordmannP.2010; Worldwide dissemination of the bla OXA-23 carbapenemase gene of Acinetobacter baumannii
. Emerg Infect Dis 16:35–40
PerezF.,
HujerA. M.,
HujerK. M.,
DeckerB. K.,
RatherP. N.,
BonomoR. A.2007; Global challenge of multidrug-resistant Acinetobacter baumannii
. Antimicrob Agents Chemother 51:3471–3484[CrossRef]
StoevaT.,
HigginsP. G.,
BojkovaK.,
SeifertH.2008; Clonal spread of carbapenem-resistant OXA-23-positive Acinetobacter baumannii in a Bulgarian university hospital. Clin Microbiol Infect 14:723–727[CrossRef]
TurtonJ. F.,
WoodfordN.,
GloverJ.,
YardeS.,
KaufmannM. E.,
PittT. L.2006a; Identification of Acinetobacter baumannii by detection of the bla OXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol 44:2974–2976[CrossRef]
TurtonJ. F.,
WardM. E.,
WoodfordN.,
KaufmannM. E.,
PikeR.,
LivermoreD. M.,
PittT. L.2006b; The role of IS Aba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii
. FEMS Microbiol Lett 258:72–77[CrossRef]
ZhanelG. G.,
DeCorbyM.,
LaingN.,
WeshnoweskiB.,
VashishtR.,
TailorF.,
NicholK. A.,
WierzbowskiA.,
BaudryP. J.other authors2008; Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005–2006. Antimicrob Agents Chemother 52:1430–1437[CrossRef]
ZhouH.,
PiB. R.,
YangQ.,
YuY. S.,
ChenY. G.,
LiL. J.,
ZhengS. S.2007; Dissemination of imipenem-resistant Acinetobacter baumannii strains carrying the IS Aba1 bla OXA-23 genes in a Chinese hospital. J Med Microbiol 56:1076–1080[CrossRef]
ZongZ.,
LuX.,
ValenzuelaJ. K.,
PartridgeS. R.,
IredellJ.2008; An outbreak of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemase in western China. Int J Antimicrob Agents 31:50–54[CrossRef]
Increasing imipenem resistance and dissemination of the ISAba1-associated blaOXA-23 gene among Acinetobacter baumannii isolates in an intensive care unit